Tiffany, Kors to Re...
Health Care: Drugs
Horizon Pharma Inc (HZNP: NASDAQ)
$2.40 0.01 | 0.42%
05/24/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 22.98M | 6.94M | 2.38M | 0.00 |
| Cost of Sales | 7.12M | 2.35M | 324.00K | 0.00 |
| Gross Operating Profit | 15.85M | 4.59M | 2.05M | 0.00 |
| Selling, General, and Administrative Expenses | 69.00M | 35.32M | 24.17M | 7.90M |
| Research & Development | 16.84M | 15.36M | 17.70M | 10.89M |
| Operating Income before D & A (EBITDA) | -69.99M | -46.09M | -39.82M | -18.79M |
| Depreciation & Amortization | 5.54M | 4.93M | 3.94M | 845.00K |
| Interest Income | 0.00 | 0.00 | 28.00K | 25.00K |
| Other Income - Net | -2.91M | -1.02M | 19.05M | 478.00K |
| Special Income / Charges | 0.00 | -69.62M | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -78.44M | -121.66M | -24.67M | -19.13M |
| Interest Expense | 14.52M | 6.28M | 3.05M | 2.21M |
| Pre-Tax Income | -92.96M | -127.95M | -27.72M | -21.34M |
| Income Taxes | -5.17M | -14.68M | -660.00K | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -87.79M | -113.26M | -27.06M | -20.50M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -87.79M | -113.26M | -27.06M | -20.50M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -87.79M | -113.26M | -27.06M | -20.50M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-87.79M | -43.64M | -27.06M | -20.50M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -87.79M | -113.26M | -27.06M | -20.50M |
| Basic EPS from Continuing Ops. | -2.26 | -12.56 | 0.00 | 0.00 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -2.26 | -12.56 | 0.00 | 0.00 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -2.26 | -12.56 | 0.00 | 0.00 |
| Basic Normalized Net Income/Share | -2.26 | -4.84 | n.a. | n.a. |
| EPS fr Continuing Ops. | -2.26 | -12.56 | 0.00 | 0.00 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -2.26 | -12.56 | 0.00 | 0.00 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -2.26 | -12.56 | 0.00 | 0.00 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-2.26 | -4.84 | n.a. | n.a. |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with HZNP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorDrugs Facing FDA Approval i...
- Usersuziltd
- ContributorBreakout Stocks Of The Week...
- Contributor4 Drug Stocks Facing FDA Ap...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
Latest HZNP Headlines from TheStreet
- 3 Stocks Under $10 Making Big Moves 03.15.13 | 07:03 am
- January Effect Stock Picks Here Are 7 Possible Winners For 2013 12.28.12 | 03:12 pm
- Shorting Alexza Pharma On FDA's Adasuve Approval 12.19.12 | 07:12 am
- 11 Stocks With Significant Institutional And Insider Buying 12.18.12 | 06:12 pm
- 10 Stocks With Bullish Institutional And Insider Buying Activities 12.04.12 | 04:12 pm
- 5 Stocks Insiders Love Right Now 10.03.12 | 01:10 pm
- Horizon Pharma's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.10.12 | 02:08 pm
- Biotech Stock Mailbag: Amarin, Sarepta 07.27.12 | 06:07 am
- Horizon Pharma: Rayos FDA Approval Thursday Seems Likely 07.25.12 | 10:07 am
- 28 Drugs Facing FDA Approval in 2012-2013 07.24.12 | 07:07 am
Press Releases for HZNP
- Horizon Pharma Announces Completion Of Sales Force Expansion - PR Newswire 10.01.12 | 07:10 am
- Horizon Pharma Announces Receipt Of Two Additional U.S. Patent Allowances For DUEXIS® - PR Newswire 09.28.12 | 07:09 am
- Horizon Pharma Announces FDA Approval Of RAYOS® (prednisone) Delayed-Release Tablets For Rheumatoid Arthritis And Multiple Additional Indications - PR Newswire 07.26.12 | 04:07 pm
- The Grünenthal Group Enters Into Exclusive Agreement With Horizon Pharma For Commercialization Of DUEXIS® In Latin America - PR Newswire 06.19.12 | 08:06 am
- Horizon Pharma Enters Into Exclusive Agreement With Grunenthal For Commercialization Of DUEXIS® In Latin America - PR Newswire 06.19.12 | 07:06 am
- Horizon Pharma And Mallinckrodt, The Pharmaceuticals Business Of Covidien, Enter Into Co-Promotion Agreement For DUEXIS® In The United States - PR Newswire 06.18.12 | 06:06 am
- Horizon Pharma Announces Issuance Of U.S. Patent Covering RAYOS (delayed-release Prednisone) - PR Newswire 05.29.12 | 07:05 am
Partner Headlines for HZNP
- Horizon Pharma Earnings Preview: Get Ahead of the Analysts - Wall St. Cheat Sheet 05.09.13 | 08:05 am
- Pre-Market Earnings Report for March 18, 2013 : KIOR, IMOS, NMRX, TA, HWCC, INSM, AMRC, PTX, STRL, HZNP, UTSI, DEXO - NASDAQ 03.15.13 | 08:03 pm
- The January Effect And 3 Biopharma Stocks - Seeking Alpha 11.09.12 | 09:11 am
- From Earlier: Horizon Pharma Announces US Patent for Rayos Tablet - Benzinga 10.15.12 | 09:10 am
- Huge Insider Buy Makes This $3.50 Biopharma Stock An Intriguing Speculative Play - Seeking Alpha 10.07.12 | 08:10 am
- Morning Market Losers - Benzinga 09.20.12 | 01:09 pm
- A Pullback Would Be Healthy For Repros Therapeutics - Seeking Alpha 09.20.12 | 09:09 am
- 5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year - Seeking Alpha 08.28.12 | 09:08 am
- 6 Healthcare Stocks With Pending August Catalysts - Seeking Alpha 08.01.12 | 09:08 am
- 4 Hot Healthcare Stocks Making Mid-Week Noise - Seeking Alpha 07.25.12 | 09:07 am
